Latest News Releases
 
*DISCLAIMER*: Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, Frankly and this Station make no warranties or representations in connection therewith.
Global Human Enhancement Market Analysis & Trends Report 2018: Market Opportunities and Recommendations
Global Human Enhancement Market Analysis & Trends Report 2018: Market Opportunities and Recommendations

The "Global Human Enhancement Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The Global Human Enhancement Market is poised to grow strong during...

Lilly Declares Third-Quarter 2018 Dividend
Lilly Declares Third-Quarter 2018 Dividend

The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2018 of $0.5625 per share on outstanding common stock.

Data Provide Further Insight into the Consistent Efficacy Benefits of MAVENCLAD™ in Relapsing MS
Data Provide Further Insight into the Consistent Efficacy Benefits of MAVENCLAD™ in Relapsing MS

Post-hoc analysis of CLARITY study suggests consistent clinical and Magnetic Resonance Imaging efficacy in subgroups of both younger and older adults treated with MAVENCLAD™ (cladribine tablets)Using an EMA-recommended...

Global Microbial Enhanced Oil Recovery Market 2018-2022
Global Microbial Enhanced Oil Recovery Market 2018-2022

About Microbial Enhanced Oil Recovery Microbial enhanced oil recovery is a tertiary oil recovery process that involves the use of microorganisms and their metabolites to reduce the residual oil saturation of reservoirs...

Global Pathology Consumables Market 2018-2022
Global Pathology Consumables Market 2018-2022

About Pathology Consumables Pathology consumables are laboratory commodities used for the preparation of cell or tissue samples to identify abnormalities in the sample. Read the full report:...

Therapies and Diagnostics for Ovarian Cancer: Global Markets to 2022
Therapies and Diagnostics for Ovarian Cancer: Global Markets to 2022

Report Scope: This report will provide a detailed overview of ovarian cancer, highlighting treatment guidelines with information on the current and potential global market for ovarian cancer and treatments and testing...

Elekta Unity, World's First High-Field MR-Linac, Receives CE Mark
Elekta Unity, World's First High-Field MR-Linac, Receives CE Mark

New radiation therapy system will now be implemented clinically in Europe, ushering in a transformation in precision and personalized cancer treatment

The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players
The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players

The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players Download the full report: https://www.reportbuyer.com/product/5439660 Summary The worldwide...

Single Blood Drop Analysis: Technologies and Global Market
Single Blood Drop Analysis: Technologies and Global Market

Report Scope: The scope of this study entails the current market for blood analyzers, especially the single blood drop analyzer.The report also includes regulatory aspects, current and developing technologies, market...

The global multiplex assays market is projected to grow at a CAGR of 7.5%
The global multiplex assays market is projected to grow at a CAGR of 7.5%

The global multiplex assays market is projected to grow at a CAGR of 7.5%. The global multiplex assays market is projected to reach USD 3.35 billion in 2023 from USD 2.33 billion in 2018, at CAGR of 7.5%. Multiplex assays...

Growing Demand for Biotechnologies are Expected to Grow
Growing Demand for Biotechnologies are Expected to Grow

Data published by Grand View Research, Inc., indicates that the global biotechnology market size is expected to reach USD 604.40 Billion by 2020. This is due to the increasing demand for sophisticated biotech-based...

Milestone Pharmaceuticals Announces Launch of OutsmartPSVT.com Supporting Patients with PSVT, a Common and Underdiagnosed Heart Disorder
Milestone Pharmaceuticals Announces Launch of OutsmartPSVT.com Supporting Patients with PSVT, a Common and Underdiagnosed Heart Disorder

Milestone Pharmaceuticals USA Inc., a clinical stage cardiovascular company, today announced the launch of OutsmartPSVT.com, a new educational online resource for patients living with a recurring and sporadic heart...

CE Mark and Health Canada Regulatory Approvals for Datum Dental's OSSIX Bone
CE Mark and Health Canada Regulatory Approvals for Datum Dental's OSSIX Bone

Datum Dental, Ltd, leading provider of OSSIX® brand innovative solutions for bone and tissue regeneration for dentistry, proudly announces major regulatory clearances for OSSIX™ Bone with CE Mark in Europe and Health...

Chronicled and OCEASOFT Strategic Partnership to Deliver Blockchain-Integrated Bluetooth Temperature Monitoring Solution in Life Science Industry
Chronicled and OCEASOFT Strategic Partnership to Deliver Blockchain-Integrated Bluetooth Temperature Monitoring Solution in Life Science Industry

Chronicled, Inc. a smart supply chain solutions company based in San Francisco, CA, and OCEASOFT, a data logging company based in Montpellier, France, today announced a strategic partnership to cross-sell and integrate...

Concordia International Corp. Announces Amendments to its CBCA Plan of Arrangement in Connection with its Recapitalization Transaction
Concordia International Corp. Announces Amendments to its CBCA Plan of Arrangement in Connection with its Recapitalization Transaction

OAKVILLE, ON, June 18, 2018 /PRNewswire/ - Concordia International Corp. ("Concordia" or the "Company") (TSX: CXR) announced today that, in connection with the previously announced proposed recapitalization transaction...

FDA Approves the Next Generation of Customized LASIK Treatment with iDESIGN Refractive Studio
FDA Approves the Next Generation of Customized LASIK Treatment with iDESIGN Refractive Studio

Johnson & Johnson Vision announced today the U.S. Food and Drug Administration (FDA) approval of the iDESIGN Refractive Studio, making it the only system to use topography-integrated, wavefront-guided technology.2 This...

Leviticus Cardio Announces Successful Animal Trial Demonstrating Wireless Power to Jarvik 2000
Leviticus Cardio Announces Successful Animal Trial Demonstrating Wireless Power to Jarvik 2000

Leviticus Cardio, inventor of wireless technology for certain medical devices, announces the successful animal implantation of the world's first Hybrid Wireless Fully Implanted Ventricular Assisted System or "Hybrid...

EFIC: Fresh Ideas in Pain Research
EFIC: Fresh Ideas in Pain Research

Creative approaches to research by young scientists provide opportunity for new and challenging thinking to benefit patients who suffer from pain.To move such approaches from a conceptual framework to a research project,...

National Advisory Committee on Immunization (NACI) recommends SHINGRIX for the prevention of shingles for adults aged 50 and up
National Advisory Committee on Immunization (NACI) recommends SHINGRIX for the prevention of shingles for adults aged 50 and up

MISSISSAUGA, ON, June 18, 2018 /CNW/ - The National Advisory Committee on Immunization (NACI) has made a strong recommendation for SHINGRIX, GSK's vaccine for the prevention of shingles. NACI recommends SHINGRIX should...

Thermo Fisher Scientific Launches Ion AmpliSeq HD Technology
Thermo Fisher Scientific Launches Ion AmpliSeq HD Technology

Thermo Fisher Scientific today announced the launch of its Ion AmpliSeq HD technology, the latest next-generation library preparation innovation that, for the first time, provides clinical researchers with the flexibility...

GammaDelta Therapeutics Appoints Michael Koslowski as CMO
GammaDelta Therapeutics Appoints Michael Koslowski as CMO

GammaDelta Therapeutics Ltd, an emerging biotech company developing novel immunotherapies for cancer and other diseases announced today that it has strengthened its leadership team with the appointment of Michael...

A diabetes diagnosis later in life may signal early pancreatic cancer in African Americans and Latinos
A diabetes diagnosis later in life may signal early pancreatic cancer in African Americans and Latinos

Each year, more than one million Americans are diagnosed with adult-onset diabetes mellitus, also known as type 2 diabetes. The new diagnosis comes with a long list of potential complications: high blood pressure, nerve...

Aprea Therapeutics Presents Results From Phase Ib/II Clinical Study of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 European Hematology Association (EHA) Annual Meeting in Stockholm
Aprea Therapeutics Presents Results From Phase Ib/II Clinical Study of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 European Hematology Association (EHA) Annual Meeting in Stockholm

Aprea Therapeutics presented results at the 2018 EHA Annual Meeting from its Phase Ib/II clinical study in MDS. The ongoing study is evaluating the safety and efficacy of APR-246 in combination with azacitidine for the...

Updated Preliminary Data from SMA FIREFISH Program in Type 1 Babies Presented at the CureSMA Conference
Updated Preliminary Data from SMA FIREFISH Program in Type 1 Babies Presented at the CureSMA Conference

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the presentation of updated interim clinical data from Part 1 of the FIREFISH study investigating risdiplam (RG7916) in babies with Type 1 Spinal Muscular Atrophy...

Phase 3 QuANTUM-R Study Demonstrates Daiichi Sankyo's Quizartinib Significantly Prolongs Overall Survival as Single Agent Compared to Chemotherapy in Patients with Relapsed/Refractory AML with FLT3-ITD Mutations
Phase 3 QuANTUM-R Study Demonstrates Daiichi Sankyo's Quizartinib Significantly Prolongs Overall Survival as Single Agent Compared to Chemotherapy in Patients with Relapsed/Refractory AML with FLT3-ITD Mutations

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that positive results from the pivotal QuANTUM-R phase 3 study of single agent quizartinib were presented today as a late-breaking oral presentation in...

Novartis JULIET trial of Kymriah demonstrates more than one-year durability of responses in adults with relapsed or refractory DLBCL
Novartis JULIET trial of Kymriah demonstrates more than one-year durability of responses in adults with relapsed or refractory DLBCL

Novartis today announced 14-month results from the pivotal JULIET clinical trial showing ongoing durable responses are achievable with Kymriah® (tisagenlecleucel) when administered to adult patients with relapsed or...

European Hematology Association: iNNOVATE Study: Ibrutinib Plus Rituximab for Patients With Waldenström's Macroglobulinemia
European Hematology Association: iNNOVATE Study: Ibrutinib Plus Rituximab for Patients With Waldenström's Macroglobulinemia

Waldenström's Macroglobulinemia (WM) is a rare type of blood cancer. Since WM is rare, it is difficult to conduct large clinical studies and determine a standard treatment for the disease. Rituximab, a therapy used to...

Indivior Is Granted Temporary Restraining Order
Indivior Is Granted Temporary Restraining Order

Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. District Court for the District of New Jersey has granted Indivior a temporary restraining order (TRO) that compels Dr. Reddy's (DRL)...

Global Medication Pouch Inspection System Market Analysis & Trends 2018-2027 by Machine Type, Operating Speed, End-User & Geography
Global Medication Pouch Inspection System Market Analysis & Trends 2018-2027 by Machine Type, Operating Speed, End-User & Geography

The "Global Medication Pouch Inspection System Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The Global Medication Pouch Inspection Systems...

Pri-Med Launches Complete Online Coverage of Live Events
Pri-Med Launches Complete Online Coverage of Live Events

Pri-Med, a leading provider of continuing medical education for primary care providers, has begun to make its Annual Conference CME sessions available in nearly real time. Taking a cue from popular consumer sites that make...